Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients.

Journal of managed care pharmacy : JMCP

Volumn 10, Issue 5, 2004, Pages 404-411

  Abughosh, Susan M ^a   Kogut, Stephen J ^a   Andrade, Susan E ^a   Larrat, Paul ^a   Gurwitz, Jerry H ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CLASSIFICATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; HYPERTENSION; MALE; MORTALITY; RETROSPECTIVE STUDY; STATISTICS; TREATMENT REFUSAL; UNITED STATES;

AGED; ANTILIPEMIC AGENTS; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MORTALITY; NEW ENGLAND; RETROSPECTIVE STUDIES; TREATMENT REFUSAL;

EID: 6044257243     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2004.10.5.404     Document Type: Article

References (0)